Biomerica Inc. (BMRA)
NASDAQ: BMRAHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
At close: Oct 7, 4:00 PM ET · Delayed 15 min
BMRA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $8.78M
- Forward P/E
- 4.90
- EPS (TTM)
- -$1.30
- Dividend yield
- None
- 52-week range
- 1.45 – 3.21
- Day range
- 1.90 – 2.10
- Volume / Avg
- 34.54K / 70.44K
- Beta
- —
- Shares outstanding
- 4.60M
- Next earnings
- Oct 13, 2026
52-week range
BMRA stock today
Biomerica (BMRA) closed at $1.91 on Oct 7, down 10.75% (-$0.23), versus the S&P 500's 0.22% decline. Trading was light, with 34.54K shares changing hands, about 49% of the average daily volume. At this level, BMRA sits in the middle of its 52-week range of $1.45 to $3.21: 40.5% below the high, set on Oct 20, 2025 and 31.7% above the low.
BMRA is down 24.2% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 32.7%. Biomerica has posted a net loss over the last twelve months (EPS of -$1.30), so its P/E ratio is not meaningful. The company is scheduled to report Aug/2026 results on Oct 13.
Summary generated from market data by MetaCap's automated system. Methodology
About Biomerica
Company profile- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
Earnings
Earnings history- Next report
- Oct 13, 2026
Biomerica peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| VNRXVolitionRX Limited | 0.226 | -6.96% | $6.79M | vs BMRA |
| CDIOCardio Diagnostics Holdings Inc. | 1.96 | -2.00% | $5.80M | vs BMRA |
| TRIBTrinity Biotech plc ADR | 6.75 | -5.59% | $5.49M | vs BMRA |
| QCLSQ/C Technologies Inc. | 0.632 | -8.42% | $5.18M | vs BMRA |
| VRAXVirax Biolabs Group Limited | 2.11 | +3.94% | $2.84M | vs BMRA |
| ICCCImmuCell Corporation | 9.69 | -2.81% | $88.01M | vs BMRA |
| IMDXInsight Molecular Diagnostics Inc. | 3.46 | +2.37% | $113.23M | vs BMRA |
| NNNNAnbio Biotechnology Class A | 4.90 | 0.00% | $215.07M | vs BMRA |
Indexes, lists and sector
Biomerica stock FAQ
What is Biomerica's stock price today?
BMRA last traded at $1.91 as of Oct 7, 4:00 PM EDT, down 10.75% on the day. Prices are delayed at least 15 minutes.
Does Biomerica pay a dividend?
No. Biomerica does not currently pay a regular cash dividend.
When is Biomerica's next earnings date?
Biomerica is expected to report earnings on Tuesday, October 13, 2026.
Has BMRA ever split its stock?
Yes. The most recent BMRA stock split was a 1-for-8 split on Apr 21, 2025, one of 2 splits on record.
What is the BMRA 52-week high?
The 52-week high for BMRA is $3.21 and the 52-week low is $1.45. The stock is currently 40.5% below its high.